Brain Pathogenesis and Potential Therapeutic Strategies in Myotonic Dystrophy Type 1

by Jie Liu, Jie Liu, Jie Liu, Zhen-Ni Guo, Zhen-Ni Guo, Zhen-Ni Guo, Xiu-Li Yan, Yi Yang, Yi Yang, Yi Yang, Shuo Huang, Shuo Huang, Shuo Huang
Published 2021

Deciphering the mechanisms underlying brain alterations and cognitive impairment in congenital myotonic dystrophy

by Thiéry De Serres-Bérard, Marion Pierre, Mohamed Chahine, Jack Puymirat
Published 2021

Expanded DMPK repeats in dizygotic twins referred for diagnosis of autism versus absence of expanded DMPK repeats at screening of 330 children with autism

by Musova Z, Hancarova M, Havlovicova M, Pourova R, Hrdlicka M, Kraus J, Trkova M, Stejskal D, Sedlacek Z
Published 2016

Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness

by Omori Y, Kanbayashi T, Imanishi A, Tsutsui K, Sagawa Y, Kikuchi YS, Takeshima M, Yoshizawa K, Uemura S, Shimizu T
Published 2018